Human Gene TherapyVol. 3, No. 2 News and CommentsThe Treatment of Patients with Melanoma Using Interleukin-2, Interleukin-4 and Tumor Infiltrating Lymphocytes. University of PittsburghPrincipal Investigator Michael T. Lotze, Co-investigators Joshua T. Rubin, Howard D. Edington, Mitchell G. Posner, Norman Wolmark, Associate investigators Ronald B. Herberman, Theresa L. Whiteside, Elaine Elder, Linda Dudjak, James Snyder, Luke Chelluri, Kathy Hayes, John M. Kirkwood, Marc Ernstoff, Daniel R. Vlock, Barry Lembcrsky, Joseph Glorioso, William Futrell, Samuel Yousem, Robert Moen, French Anderson, and Roger DayPrincipal Investigator Michael T. LotzeSearch for more papers by this author, Co-investigators Joshua T. RubinSearch for more papers by this author, Howard D. EdingtonSearch for more papers by this author, Mitchell G. PosnerSearch for more papers by this author, Norman WolmarkSearch for more papers by this author, Associate investigators Ronald B. HerbermanSearch for more papers by this author, Theresa L. WhitesideSearch for more papers by this author, Elaine ElderSearch for more papers by this author, Linda DudjakSearch for more papers by this author, James SnyderSearch for more papers by this author, Luke ChelluriSearch for more papers by this author, Kathy HayesSearch for more papers by this author, John M. KirkwoodSearch for more papers by this author, Marc ErnstoffSearch for more papers by this author, Daniel R. VlockSearch for more papers by this author, Barry LembcrskySearch for more papers by this author, Joseph GloriosoSearch for more papers by this author, William FutrellSearch for more papers by this author, Samuel YousemSearch for more papers by this author, Robert MoenSearch for more papers by this author, French AndersonSearch for more papers by this author, and Roger DaySearch for more papers by this authorPublished Online:12 Jun 2008https://doi.org/10.1089/hum.1992.3.2-167AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited ByImmunotherapy of metastatic renal cell cancerAnnals of Oncology, Vol. 7, No. 9Autologous Bone Marrow Transplantation27 September 2008 | Critical Reviews in Clinical Laboratory Sciences, Vol. 32, No. 1Cytokine combinations in immunotherapy for solid tumors: a reviewCancer Immunology Immunotherapy, Vol. 37, No. 4Autologous tumor cell killing activity of tumor-associated lymphocytes in patients with head and neck carcinomasBiotherapy, Vol. 6, No. 2Human genetic therapyMolecular Aspects of Medicine, Vol. 14, No. 6Human Gene TherapyScience, Vol. 256, No. 5058 Volume 3Issue 2Apr 1992 To cite this article:Principal Investigator Michael T. Lotze, Co-investigators Joshua T. Rubin, Howard D. Edington, Mitchell G. Posner, Norman Wolmark, Associate investigators Ronald B. Herberman, Theresa L. Whiteside, Elaine Elder, Linda Dudjak, James Snyder, Luke Chelluri, Kathy Hayes, John M. Kirkwood, Marc Ernstoff, Daniel R. Vlock, Barry Lembcrsky, Joseph Glorioso, William Futrell, Samuel Yousem, Robert Moen, French Anderson, and Roger Day.The Treatment of Patients with Melanoma Using Interleukin-2, Interleukin-4 and Tumor Infiltrating Lymphocytes. University of Pittsburgh.Human Gene Therapy.Apr 1992.167-177.http://doi.org/10.1089/hum.1992.3.2-167Published in Volume: 3 Issue 2: June 12, 2008PDF download